Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...

Slashing adverse drug reactions through pharmacogenetics and advanced AI could help rehabilitate the pharmaceutical ...

Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...

AI is reshaping life sciences. Learn how compliant, explainable, and genuinely useful systems move from pilot to scale and ...

Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of $256 million, a company spokesperson told Reuters on Monday.

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...

These AI adoption initiatives reflect the Company's commitment to leveraging AI to drive efficiency and innovation across the organization. About TNL Mediagene ...

As artificial intelligence (AI) continues to challenge the financial services industry, the role of leadership and its technology decision makers becomes more critical than ever before. Successful ...

The Chan Zuckerberg Initiative (CZI) reports its latest AI model aimed at helping researchers better understand how cells ...